Hims & Hers Health, Inc. (HIMS) Q3 Revenues Beat; Guides Above
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Hims & Hers Health, Inc. Reports Third Quarter 2021 Financial Results
November 10, 2021 4:01 PM ESTQ3 2021 revenue grows 79% year-over-year to $74.2 million
Q3 2021 ending member subscriptions grow 95% year-over-year to 551,000
Exceeds Q3 2021 revenue guidance, raises full year 2021 guidance
SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (Hims & Hers, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported financial results for the third quarter ending September 30, 2021.
This latest quarter of results shows that our vision to create a new front door to healthcare is resonating, said Andrew Dudum, CEO and... More
